195 related articles for article (PubMed ID: 20332300)
1. Lung cancer biomarkers: FISHing in the sputum for risk assessment and early detection.
Gomperts BN; Spira A; Elashoff DE; Dubinett SM
Cancer Prev Res (Phila); 2010 Apr; 3(4):420-3. PubMed ID: 20332300
[TBL] [Abstract][Full Text] [Related]
2. Multiple genetic and epigenetic biomarkers for lung cancer detection in cytologically negative sputum and a nested case-control study for risk assessment.
Hsu HS; Chen TP; Wen CK; Hung CH; Chen CY; Chen JT; Wang YC
J Pathol; 2007 Dec; 213(4):412-9. PubMed ID: 17973238
[TBL] [Abstract][Full Text] [Related]
3. Interphase cytogenetics of sputum cells for the early detection of lung carcinogenesis.
Prindiville SA; Ried T
Cancer Prev Res (Phila); 2010 Apr; 3(4):416-9. PubMed ID: 20332302
[TBL] [Abstract][Full Text] [Related]
4. A review of novel biological tools used in screening for the early detection of lung cancer.
Ghosal R; Kloer P; Lewis KE
Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
[TBL] [Abstract][Full Text] [Related]
5. Early detection of lung cancers - Comparison of computed tomography, cytology and fuzzy-based tumor markers panels.
Schneider J
Cancer Biomark; 2010; 6(3-4):149-62. PubMed ID: 20660961
[TBL] [Abstract][Full Text] [Related]
6. Using molecular markers in sputum for the early detection of lung cancer: a review.
Kennedy TC; Hirsch FR
Lung Cancer; 2004 Aug; 45 Suppl 2():S21-7. PubMed ID: 15552778
[TBL] [Abstract][Full Text] [Related]
7. Computerized analysis of cytology and fluorescence in situ hybridization (FISH) in induced sputum for lung cancer detection.
Guber A; Greif J; Rona R; Fireman E; Madi L; Kaplan T; Yemini Z; Gottfried M; Katz RL; Daniely M
Cancer Cytopathol; 2010 Oct; 118(5):269-77. PubMed ID: 20665655
[TBL] [Abstract][Full Text] [Related]
8. [Application of fluorescence in situ hybridization (FISH) in sputum cytologic diagnosis of lung cancer].
Jia D; Zhang Z; Liu S
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):477-9. PubMed ID: 11235568
[TBL] [Abstract][Full Text] [Related]
9. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
[TBL] [Abstract][Full Text] [Related]
11. Screening and early detection of lung cancer.
Van't Westeinde SC; van Klaveren RJ
Cancer J; 2011; 17(1):3-10. PubMed ID: 21263260
[TBL] [Abstract][Full Text] [Related]
12. Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer.
Varella-Garcia M; Kittelson J; Schulte AP; Vu KO; Wolf HJ; Zeng C; Hirsch FR; Byers T; Kennedy T; Miller YE; Keith RL; Franklin WA
Cancer Detect Prev; 2004; 28(4):244-51. PubMed ID: 15350627
[TBL] [Abstract][Full Text] [Related]
13. Use of tumor markers in lung cancer.
Strauss GM; Skarin AT
Hematol Oncol Clin North Am; 1994 Jun; 8(3):507-32. PubMed ID: 8707770
[TBL] [Abstract][Full Text] [Related]
14. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China.
Qiao YL; Tockman MS; Li L; Erozan YS; Yao SX; Barrett MJ; Zhou WH; Giffen CA; Luo XC; Taylor PR
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):893-900. PubMed ID: 9367062
[TBL] [Abstract][Full Text] [Related]
15. Clinical detection of lung cancer progression markers.
Tockman MS
J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
[TBL] [Abstract][Full Text] [Related]
16. Current challenges in lung cancer early detection biomarkers.
Montuenga LM; Pio R
Eur J Cancer; 2009 Sep; 45 Suppl 1():377-8. PubMed ID: 19775637
[No Abstract] [Full Text] [Related]
17. Molecular diagnostic markers for lung cancer in sputum and plasma.
Wang YC; Hsu HS; Chen TP; Chen JT
Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
[TBL] [Abstract][Full Text] [Related]
18. Screening for oral premalignancy and cancer: what platform and which biomarkers?
Lingen MW
Cancer Prev Res (Phila); 2010 Sep; 3(9):1056-9. PubMed ID: 20798207
[TBL] [Abstract][Full Text] [Related]
19. The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence.
Varella-Garcia M; Schulte AP; Wolf HJ; Feser WJ; Zeng C; Braudrick S; Yin X; Hirsch FR; Kennedy TC; Keith RL; Barón AE; Belinsky SA; Miller YE; Byers T; Franklin WA
Cancer Prev Res (Phila); 2010 Apr; 3(4):447-53. PubMed ID: 20332298
[TBL] [Abstract][Full Text] [Related]
20. Gene-promoter hypermethylation as a biomarker in lung cancer.
Belinsky SA
Nat Rev Cancer; 2004 Sep; 4(9):707-17. PubMed ID: 15343277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
